Skip to main content

Table 3 Response of SCNSL patients after induction therapy

From: Treatment of secondary central nervous system involvement in systemic aggressive B cell lymphoma using R-MIADD chemotherapy: a single-center study

Response Total New disease Refractory disease Relapse disease
N = 19 % N = 10 % N = 5 % N = 4 %
CR 11 57.9 7 70 2 40 2 50
PR 2 10.5 1 10 0 0 1 25
WBRT* 5 26.3 2 20 2 40 1 25
Death 1 5.3 0 0 1 20 0 0
  1. CR complete remission, PR partial remission, SD stable disease, PD progression disease, WBRT whole brain radiotherapy
  2. *WBRT indicated SCNSL who turned to WBRT during the induction treatment